{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:55:25Z","timestamp":1759146925718},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1212\/wnl.51.5.1297","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:36:49Z","timestamp":1336916209000},"page":"1297-1302","source":"Crossref","is-referenced-by-count":25,"title":["Muscarinic cholinergic receptors in human narcolepsy"],"prefix":"10.1212","volume":"51","author":[{"given":"Y.","family":"Sudo","sequence":"first","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Suhara","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Honda","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Nakajima","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Okubo","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Suzuki","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nakashima","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Okauchi","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Sasaki","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Matsushita","sequence":"additional","affiliation":[{"name":"From the Division of Advanced Technology for Medical Imaging (Drs. Sudo, Suhara, Okubo, Suzuki, and Yoshikawa, T. Okauchi, and Dr. Sasaki), National Institute of Radiological Sciences, Chiba; Department of Neuropsychiatry (Drs. Sudo, Nakajima, Nakashima, and Matsushita), Faculty of Medicine, University of Tokyo; Seiwa Hospital (Dr. Honda), Neuropsychiatric Research Institute; and Core Research for Evolutional Science and Technology (CREST) (Drs. Sudo and Suhara, and T. Okauchi), Japan Science and..."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"2","volume":"52","year":"1997","unstructured":"Nishino S, Mignot E. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 1997;52:27-78.","journal-title":"Prog Neurobiol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Tononi G Pompeiano O. Pharmacology of the cholinergic system. In: Kales A. Pharmacology of sleep. Berlin: Springer-Verlag 1995:143-210.","DOI":"10.1007\/978-3-642-57836-6_7"},{"key":"e_1_3_1_4_2","first-page":"5","volume":"59","year":"1994","unstructured":"Reid MS, Tafti M, Geary JN, et al. Cholinergic mechanisms in canine narcolepsy-I. Modulation of cataplexy via local drug administration into the pontine reticular formation. Neuroscience 1994;59:511-522.","journal-title":"Neuroscience"},{"key":"e_1_3_1_5_2","first-page":"4","volume":"17","year":"1994","unstructured":"Reid MS, Tafti M, Nishino S, Siegel JM, Dement WC, Mignot E. Cholinergic regulation of cataplexy in canine narcolepsy in the pontine reticular formation is mediated by M2 muscarinic receptors. Sleep 1994;17:424-435.","journal-title":"Sleep"},{"key":"e_1_3_1_6_2","first-page":"5","volume":"59","year":"1994","unstructured":"Reid MS, Siegel JM, Dement WC, Mignot E. Cholinergic mechanisms in canine narcolepsy-II. Acetylcholine release in the pontine reticular formation is enhanced during cataplexy. Neuroscience 1994;59:523-530.","journal-title":"Neuroscience"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90324-2"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/sleep\/9.1.1"},{"key":"e_1_3_1_9_2","first-page":"1","volume":"6","year":"1995","unstructured":"Nitz D, Andersen A, Fahringer H, Nienhuis R, Mignot E, Siegel J. Altered distribution of cholinergic cells in the narcoleptic dog. Neuroreport 1995;6:1521-1524.","journal-title":"Neuroreport"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9861(19970303)379:1<1::AID-CNE1>3.0.CO;2-8"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0987-7053(05)80277-1"},{"key":"e_1_3_1_12_2","first-page":"7","volume":"47","year":"1994","unstructured":"Maloteaux JM, Hermans E. Agonist-induced muscarinic cholinergic receptor internalization, recycling and degradation in cultured neuronal cells. Biochem Pharmacol 1994;47:77-88.","journal-title":"Biochem Pharmacol"},{"key":"e_1_3_1_13_2","first-page":"6","volume":"728","year":"1996","unstructured":"Rodr\u00edguez-Puertas R, Pascual J, Pazos A. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissues. Brain Res 1996;728:65-71.","journal-title":"Brain Res"},{"key":"e_1_3_1_14_2","first-page":"4","volume":"5","year":"1996","unstructured":"Hublin C. Narcolepsy: current drug treatment options. CNS Drugs 1996;5:426-436.","journal-title":"CNS Drugs"},{"key":"e_1_3_1_15_2","first-page":"2","volume":"104","year":"1984","unstructured":"Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984;104:277-286.","journal-title":"Eur J Pharmacol"},{"key":"e_1_3_1_16_2","first-page":"3","volume":"7","year":"1980","unstructured":"Sokolovsky M, Egozi Y, Kloog Y. Biochemical characterization of muscarinic receptors. Monographs in Neural Sciences 1980;7:30-40.","journal-title":"Monographs in Neural Sciences"},{"key":"e_1_3_1_17_2","first-page":"5","volume":"16","year":"1989","unstructured":"Otto CA, Mulholland GK, Perry SE, Combs R, Sherman PS, Fisher SJ. In vitro and ex vivo evaluation of cyclic aminoalkyl benzilates as potential emission tomography ligands for the muscarinic receptor. Int J Rad Appl Instrum B 1989;16:51-55.","journal-title":"Int J Rad Appl Instrum B"},{"key":"e_1_3_1_18_2","unstructured":"Diagnostic Classification Steering Committee; Thorpy MJ Chairman. International classification of sleep disorders: diagnostic and coding manual. Rochester MN: American Sleep Disorders Association 1990."},{"key":"e_1_3_1_19_2","doi-asserted-by":"crossref","unstructured":"Honda Y Juji T. HLA in narcolepsy. Heidelberg: Springer-Verlag 1988.","DOI":"10.1007\/978-3-642-83387-8"},{"key":"e_1_3_1_20_2","first-page":"3","volume":"113","year":"1994","unstructured":"Suhara T, Inoue O, Kobayashi K, Satoh T, Tateno Y. An acute effect of triazolam on muscarinic cholinergic receptor binding in the human brain measured by positron emission tomography. Psychopharmacology (Berl) 1994;113:311-317.","journal-title":"Psychopharmacology (Berl)"},{"key":"e_1_3_1_21_2","first-page":"5","volume":"5","year":"1985","unstructured":"Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations. J Cereb Blood Flow Metab 1985;5:584-590.","journal-title":"J Cereb Blood Flow Metab"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1986.1"},{"key":"e_1_3_1_23_2","first-page":"2","volume":"46","year":"1986","unstructured":"Lin SC, Olson KC, Okazaki H, Richelson E. Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine. J Neurochem 1986;46:274-279.","journal-title":"J Neurochem"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1987.tb07881.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.1986.1"},{"key":"e_1_3_1_26_2","first-page":"2","volume":"79","year":"1990","unstructured":"Andersson U, Eckern\u00e4s S\u00c5, Hartvig P, Ulin J, L\u00e5ngstr\u00f6m B, H\u00e4ggstr\u00f6m JE. Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding. J Neural Transm Gen Sect 1990;79:215-226.","journal-title":"J Neural Transm Gen Sect"},{"key":"e_1_3_1_27_2","first-page":"5","volume":"27","year":"1990","unstructured":"Dewey SL, Volkow ND, Logan J, et al. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J Neurosci Res 1990;27:569-575.","journal-title":"J Neurosci Res"},{"key":"e_1_3_1_28_2","first-page":"2","volume":"149","year":"1993","unstructured":"Suhara T, Inoue O, Kobayashi K, Suzuki K, Tateno Y. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett 1993;149:225-228.","journal-title":"Neurosci Lett"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198907063210101"},{"key":"e_1_3_1_30_2","first-page":"2","volume":"362","year":"1986","unstructured":"Cort\u00e9s R, Probst A, Tobler HJ, Palacios JM. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Res 1986;362:239-253.","journal-title":"Brain Res"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91695-8"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)91041-X"},{"key":"e_1_3_1_33_2","first-page":"6","volume":"636","year":"1994","unstructured":"Imeri L, Bianchi S, Angeli P, Mancia M. Selective blockade of different brain stem muscarinic receptor subtypes: effects on the sleep-wake cycle. Brain Res 1994;636:68-72.","journal-title":"Brain Res"},{"key":"e_1_3_1_34_2","first-page":"3","volume":"7","year":"1994","unstructured":"Shinotoh H, Asahina M, Inoue O, Suhara T, Hirayama K, Tateno Y. Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography. J Neural Transm Park Dis Dement Sect 1994;7:35-46.","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"e_1_3_1_35_2","first-page":"5","volume":"189","year":"1975","unstructured":"Hobson JA, McCarley RW, Wyzinski PW. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 1975;189:55-58.","journal-title":"Science"},{"key":"e_1_3_1_36_2","first-page":"7","volume":"89","year":"1992","unstructured":"Luebke JI, Greene RW, Semba K, Kamondi A, McCarley RW, Reiner PB. Serotonin hyperpolarizes cholinergic low-threshold burst neurons in the rat laterodorsal tegmental nucleus in vitro. Proc Natl Acad Sci USA 1992;89:743-747.","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_1_37_2","first-page":"3","volume":"59","year":"1994","unstructured":"Leonard CS, Llinas R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 1994;59:309-330.","journal-title":"Neuroscience"},{"key":"e_1_3_1_38_2","first-page":"3","volume":"13","year":"1993","unstructured":"Williams Ja, Reiner PB. Noradrenaline hyperpolarizes identified rat mesopontine cholinergic neurons in vitro. J Neurosci 1993;13:3878-3883.","journal-title":"J Neurosci"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(93)90450-T"},{"key":"e_1_3_1_40_2","first-page":"1","volume":"6","year":"1996","unstructured":"Suhara T, Sudo Y, Fukuda H, Okubo Y, Inoue O, Suzuki K. Imaging of the brain serotonin system. Eur Neuropsychopharmacol 1996;6:165. Abstract.","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_1_41_2","first-page":"7","volume":"17","year":"1997","unstructured":"Horner RL, Sanford LD, Annis D, Pack AI, Morrison AR. Serotonin at the laterodorsal tegmental nucleus suppresses rapid-eye-movement sleep in freely behaving rats. J Neurosci 1997;17:7541-7552.","journal-title":"J Neurosci"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.5.1297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T16:12:57Z","timestamp":1711555977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.5.1297"}},"subtitle":["A PET study"],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["10.1212\/WNL.51.5.1297"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.5.1297","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}